Methadone Accord Healthcare

Methadone, the active ingredient in Methadone Accord Healthcare, is a synthetic opioid presented as an oral dosage form for oral use. It treats opioid dependence and chronic pain in adult patients.

GNH USA supplies Methadone Accord Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Methadone is an opioid agonist used in the management of opioid‑related disorders and pain conditions. - Opioid dependence: suppresses withdrawal symptoms and supports maintenance therapy. - Chronic pain management: provides analgesia for moderate to severe persistent pain when other opioids are unsuitable. - Cancer‑related pain: offers palliation for severe pain in oncology patients.

Methadone may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Constipation: reduced bowel motility leading to hard stools. - Nausea: feeling of queasiness, sometimes with vomiting. - Drowsiness: increased sleepiness or fatigue. - Sweating: excessive perspiration unrelated to temperature. - Dry mouth: reduced salivation causing discomfort. - Dizziness: sensation of light‑headedness or imbalance.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - QT interval prolongation: cardiac rhythm disturbance increasing arrhythmia risk. - Severe hypotension: marked drop in blood pressure causing faintness. - Adrenal insufficiency: inadequate cortisol production leading to fatigue and weakness. - Seizures: rare episodes of uncontrolled electrical activity in the brain.

Methadone requires careful monitoring due to its potency and pharmacologic profile. - Cardiac risk assessment: evaluate QT prolongation potential before initiating therapy. - Respiratory monitoring: observe for signs of respiratory depression, especially during dose changes. - Liver function evaluation: adjust dosing in patients with hepatic impairment. - Elderly caution: start with lower doses and titrate slowly. - Discontinuation guidance: avoid abrupt cessation to prevent severe withdrawal. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Methadone interacts with several drug classes, necessitating vigilance.

Major Interactions (Avoid): - Central nervous system depressants: may cause profound sedation or respiratory depression. - Monoamine oxidase inhibitors (MAOIs): risk of serotonin syndrome and hypertensive crisis. - QT‑prolonging agents: additive effect on cardiac repolarization increasing arrhythmia risk.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): may raise methadone plasma levels. - CYP3A4 inducers (e.g., rifampin): may lower methadone concentrations, reducing efficacy. - Selective serotonin reuptake inhibitors (SSRIs): potential for enhanced serotonergic effects.